{"filing":{"accession_number":"0001193125-26-261693","cik":"0001745999","ticker":"BEAM","company_name":"Beam Therapeutics Inc.","form":"8-K","filing_date":"2026-06-08","report_date":null,"primary_document":"beam-20260603.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526261693/beam-20260603.htm"},"events":[{"id":6194,"run_id":5439,"accession_number":"0001193125-26-261693","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder voting results from Beam Therapeutics' June 3, 2026 annual meeting, covering three proposals: election of Class III directors (John Evans, John Maraganore, and Christi Shaw), ratification of Deloitte \u0026 Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The filing directly matches Item 5.07 requirements and presents tabulated vote counts for each proposal.","company_name":"Beam Therapeutics Inc.","ticker":"BEAM","filing_date":"2026-06-08","form":"8-K","submitted_at":null,"items":[{"id":5170,"accession_number":"0001193125-26-261693","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Beam Therapeutics' June 3, 2026 annual meeting, covering three proposals: election of Class III directors (John Evans, John Maraganore, and Christi Shaw), ratification of Deloitte \u0026 Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The filing directly matches Item 5.07 requirements and presents tabulated vote counts for each proposal.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T20:06:37.770924+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5170,"accession_number":"0001193125-26-261693","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Beam Therapeutics' June 3, 2026 annual meeting, covering three proposals: election of Class III directors (John Evans, John Maraganore, and Christi Shaw), ratification of Deloitte \u0026 Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The filing directly matches Item 5.07 requirements and presents tabulated vote counts for each proposal.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T20:06:37.770924+00:00","company_name":"Beam Therapeutics Inc.","ticker":"BEAM","filing_date":"2026-06-08"}]}